Antisperm Contraceptive Vaccines: Where We Are and Where We Are Going?

American Journal of Reproductive Immunology

Volumn 66, Issue 1, 2011, Pages 5-12

  Naz, Rajesh K ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contraception; Infertility; Sperm; Vaccines

Indexed keywords

A9D PROTEIN; ANTISPERM CONTRACEPTIVE VACCINE; CONTRACEPTIVE VACCINE; CPG OLIGODEOXYNUCLEOTIDE; CV ANTIGEN; DNA VACCINE; EPIDIDYMAL PROTEIN INHIBITOR; FA 1 ANTIGEN; FREUND ADJUVANT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IZUMO PROTEIN; LDH C4 PROTEIN; P10G PROTEIN; PEPTIDE VACCINE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SP56 PROTEIN; SPERM ANTIBODY; SPERM ANTIGEN; TESTIS SPECIFIC ANTIGEN 1; UNCLASSIFIED DRUG; YLP 12 ANTIGEN; ZONA PELLUCIDA PROTEIN; ZONA PELLUCIDA PROTEIN 3;

ANTIBODY ENGINEERING; ANTIBODY TITER; BINDING SITE; BLOOD TESTIS BARRIER; CASTRATION; COMPLEMENTARITY DETERMINING REGION; DRUG EFFICACY; DRUG TARGETING; GENE EXPRESSION; GENE INACTIVATION; GENETIC IDENTIFICATION; GENOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYBRIDIZATION; HYBRIDOMA; IMMUNE RESPONSE; IMMUNOCONTRACEPTION; IMMUNOGENICITY; IN VITRO STUDY; MOLECULAR CLONING; MOUSE STRAIN; MUCOSAL IMMUNITY; NONHUMAN; PASSIVE IMMUNIZATION; PHAGE DISPLAY; PLASMA CELL; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SEQUENCE HOMOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; SPERMATOGENESIS; SUBTRACTIVE HYBRIDIZATION; TH1 CELL; TH2 CELL; ZONA PELLUCIDA;

ANIMALS; ANTIGENS; CLONING, MOLECULAR; COMPLEMENTARITY DETERMINING REGIONS; CONTRACEPTION, IMMUNOLOGIC; CONTRACEPTIVE AGENTS; FEMALE; FERTILITY; HUMANS; MALE; MICE; POPULATION CONTROL; RECOMBINANT PROTEINS; SINGLE-CHAIN ANTIBODIES; SPERMATOZOA; VACCINES, CONTRACEPTIVE; VACCINES, SYNTHETIC;

EID: 79958085047     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01000.x     Document Type: Review

References (54)

1. World POPClock Projection: US Census Bureau. Available at (Accessed on January 1, 2011).
2. Henshaw SK: Unintended pregnancy in the United States. Fam Plann Perspect 1998; 30:24-29.
3. Trussel J: Contraceptive failure in the United States. Contraception 2004; 70:89-96.
4. WHO/63 News Release, November 1, 2006.
5. Naz RK, Gupta SK, Gupta JC, Vyas HK, Talwar GP: Recent advances in contraceptive vaccine development: a mini-review. Hum Reprod 2005; 20:3271-3283.
6. Talwar GP, Singh O, Pal R, Chatterjee N, Sahai P, Dhall K, Kaur K, Das SK, Suri S, Bukshee K, Saraya L, Saxena BN: A vaccine that prevents pregnancy in women. Proc Natl Acad Sci U S A 1994; 91:8532-8536.
7. Liskin L, Pile JM, Quillan WF: Vasectomy safe and simple. Popul Rep 1983; 4:61-100.
8. Krause WKH, Naz RK (eds): Immune Infertility. Springer-Verlag, Berlin, Heidelberg, Germany, 2009; pp. 1-236.
9. Allardyce RA: Effect of ingested sperm on fecundity in the rat. J Exp Med 1984; 159:1548-1553.
10. Edwards RG: Immunological control of fertility in female mice. Nature 1964; 203:50-53.
11. Menge AC: Immune reactions and infertility. J Reprod Fertil Suppl 1970; 10:171-185.
12. Baskin MJ: Temporary sterilization by injection of human spermatozoa: a preliminary report. Am J Obstet Gynecol 1932; 24:892-897.
13. Mancini RE, Andrana JA, Saracine D, Bachmann AE, Lavieri JC, Nemirovsky M: Immunological and testicular response in men sensitized with human testicular homogenate. J Clin Endocrinol Metab 1965; 25:859-875.
14. Naz RK: Vaccine for contraception targeting sperm. Immunol Rev 1999; 171:193-202.
15. The Mouse genome and the measure of man. NIH News Advisory, Retrieved from, 2002.
16. Naz RK, Rajesh P: Novel testis/sperm-specific contraceptive targets identified using gene knockout studies. Front Biosci 2005; 10:2430-2446.
17. Naz RK, Engle A: Rajnee: gene knockouts that affect male fertility: novel targets for contraception. Front Biosci 2009; 14:3994-4001.
18. Zhu X, Naz RK: Fertilization antigen-1: cDNA cloning, testis-specific expression, and immunocontraceptive effects. Proc Natl Acad Sci USA 1997; 94:4704-4709.
19. Naz RK, Zhu X, Kadam AL: Identification of human sperm peptide sequence involved in egg binding for immunocontraception. Biol Reprod 2000; 62:318-324.
20. Naz RK, Zhu X, Kadam AL: Cloning and sequencing of cDNA encoding for a novel human testis-specific contraceptive vaccinogen: role in immunocontraception. Mol Reprod Dev 2001; 60:116-127.
21. Santhanam R, Naz RK: Novel human testis-specific cDNA: molecular cloning, expression and immunobiological effects of the recombinant protein. Mol Reprod Dev 2001; 60:1-12.
22. O'Hearn PA, Liang ZG, Bambra CS, Goldberg E: Colinear synthesis of an antigen-specific B-cell epitope with a promiscuous tetanus toxin T-cell epitope: a synthetic peptide immunocontraceptive. Vaccine 1997; 15:1761-1766.
23. O'Rand MG, Beavers J, Widgren E, Tung K: Inhibition of fertility in female mice by immunization with a B-cell epitope, the synthetic sperm peptide, P10G. J Reprod Immunol 1993; 25:89-102.
24. Lea JA, van Lierop MJC, Widgren EE, Grootenhuic A, Wen Y, van Duin M, O'Rand MG: A chimeric sperm peptide induced antibodies and strain-specific reversible infertility in mice. Biol Reprod 1998; 59:527-536.
25. Hardy CM, Mobbs JK: Expression of recombinant mouse sperm protein sp56 and assessment of its potential for use as an antigen in an immunocontraceptive vaccine. Mol Reprod Dev 1999; 52:527-536.
26. O'Rand MG, Widgren EE, Sivashanmugam P, Richardson RT, Hall SH, French FS, Vande Voort CA, Ramachandra SG, Ramesh V, Jagannadha Roa A: Reversible immunocontraception in male monkeys immunized with Eppin. Science 2004; 306:1189.
27. Inoue N, Ikawa M, Isotani A, Okabe M: The immunoglobin superfamily protein izumo is required for sperm to fuse with eggs. Nature 2005; 434:234-238.
28. Naz RK, Ahmad K: Molecular identities of human sperm proteins that bind human zona pellucida: nature of sperm-zona interaction, tyrosine kinase activity and involvement of FA-1. Mol Reprod Dev 1994; 39:397-408.
29. Naz RK, Dhandapani L: Identification of human sperm proteins that interact with human zona pellucida3 (ZP3) using yeast two-hybrid system. J Reprod Immun 2010; 84:24-31.
30. Naz RK, Phillips TM, Rosenblum BB: Characterization of fertilization antigen 2 for the development of a contraceptive vaccine. Proc Natl Acad Sci USA 1986; 225:342-344.
31. Saling PM, Waibel R: Mouse sperm antigens tat participate in fertilization. III. Passive immunization with a single monoclonal antisperm antibody inhibits pregnancy and fertilization in vivo. Bio Reprod 1985; 33:537-544.
32. Naz RK: Effects of sperm-reactive antibodies present in human infertile sera on fertility of female rabbits. J Reprod Immunol 1990; 18:161-177.
33. Naz RK, Zhu X: Recombinant fertilization antigen-1 causes a contraceptive effect in actively immunized mice. Biol Reprod 1998; 59:1095-1100.
34. Naz RK, Chauhan S: Human sperm-specific peptide vaccine that causes long-term reversible contraception. Biol Reprod 2002; 64:674-680.
35. Khobarekar BG, Vernekar V, Raghavan V, Kamada M, Maegawa M, Bandivdekar AH: Evaluation of the potential of synthetic peptides of 80kDa human sperm antigen (80kDa HSA) for the development of contraceptive vaccine for male. Vaccine 2008; 26:3711-3718.
36. Naz RK: Immunocontraceptive effect of Izumo and enhancement by combination vaccination. Mol Reprod Dev 2008; 75:336-344.
37. Li P, Chan HC, He B, So SC, Chung YW, Shang Q, Zhang YD, Zhang YL: An antimicrobial peptide gene found in the male reproductive system of rats. Science 2001; 291:1783-1785.
38. Tollner TL, Overstreet JW, Branciforte D, Primakoff PD: Immunization of female cynomolgus macaques with a synthetic epitope of sperm-specific lactate dehyrogenase results in high antibody titers but does not reduce fertility. Mol Reprod Dev 2002; 62:257-264.
39. Naz RK, Bhargava KK: Antibodies to sperm surface fertilization antigen (FA-1): their specificities and site of interaction with sperm in male genital tract. Mol Reprod Dev 1990; 26:175-183.
40. Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Kelling ME, Lu Y, Wriht JE, Chou TC, Ruprecht RM: Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 2000; 6:200-206.
41. Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE, Beary H, Hayes D, Frankel SS, Birx DL, Lewis MG: Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000; 5:207-210.
42. Naz RK, Menge AC: Antisperm antibodies: origin, regulation, and sperm reactivity in human infertility. Fertil Steril 1994; 61:1001-1013.
43. Kutteh WH, Moldovenanu Z, Mestecky J: Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses 1998; 14(Suppl 1):S51-S55.
44. Woof JM, Mestecky J: Mucosal immunoglobulins. Immunol Rev 2005; 206:64-82.
45. Mestecky J, Moldoveanu Z, Russell MW: Immunologic uniqueness of the genital tract: challenge for vaccine development. Am J Reprod Immunol 2005; 53:208-214.
46. Liu MA: DNA vaccines: a review. J Intern Med 2003; 253:402-410.
47. Naz RK, Chauhan SC, Rose LP: Expression of alpha and gamma interferon receptors in the sperm cell. Mol Reprod Dev 2000; 56:189-197.
48. Naz RK: Effect of sperm DNA vaccine on fertility of female mice. Mol Reprod Dev 2006; 73:918-928.
49. Naz RK: Effect of fertilization antigen (FA-1) DNA vaccine on fertility of female mice. Mol Reprod Dev 2006; 73:1473-1479.
50. 12 peptides presented on Johnson grass mosaic virus-like particles. Vaccine 2009; 27:2948-2953.
51. Naz RK, Changanamkandath R: Passive immunization for immunocontraception: lessons learned from infectious diseases. Front BioSci 2004; 9:2457-2465.
52. Samuel AS, Naz RK: Isolation of human single chain variable fragment antibodies against specific sperm antigens for immunocontraceptive development. Hum Reprod 2008; 23:1324-1337.
53. Holliger P, Hudson PJ: Engineered antibody fragments and the rise of single domains. Nat Biotechnol 2005; 23:1126-1136.
54. Marasco WA, Sui J: The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol 2007; 25:1421-1434.